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Abstract
We characterized 53 OXA-48-producing Klebsiella pneumoniae
(OXA-48-Kp) isolated between 2011 and 2013 in 21 French
hospitals. All the isolates were genotyped using MLST and PFGE
and the population structure of the species was determined by a
nucleotide-based analysis of the entire K. pneumoniae MLST
database. Most of the OXA-48-Kp isolates also produced
CTX-M-15 and remained susceptible to imipenem and merope-
nem. The isolates were distributed into 20 STs, of which five were
dominant (ST15, ST101, ST147, ST395 and ST405). All the
OXA-48-Kp clustered in the major clade of K. pneumoniae KpI.
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The emergence of carbapenemase-producing Enterobacteria-
ceae (CPE) has become a major public health concern [1,2].
In France, OXA-48-producing Klebsiella pneumoniae
(OXA-48-Kp)represented two-thirds of the 627 cases of
CPE reported between January 2004 and September 2013 to
the mandatory national surveillance system [3]. Here, we
assess the genetic population structure of a significant sample
of the OXA-48-Kp recovered in French hospitals.
We selected 53 OXA-48-Kp isolated between 2011 and
2013 in 21 French hospitals located in 10 of the 22 regions
of France. We kept only the index isolate of each outbreak
to get a better picture of the diversity of the strains. This
represents approximately one-sixth of all the OXA-48-Kp
identified in France during the study period. All the isolates
were recovered from human samples (rectal screening or
clinical samples). Twenty-eight (53%) of the patients travelled
or were hospitalized in a foreign country in the previous
12 months and 15 (28%) did not travel abroad. The
antibiotic susceptibility was determined by the disk diffusion
method and the production of an extended-spectrum
b-lactamase (ESBL) was detected by a synergy test [4]. We
also determined the MICs of imipenem, meropenem and
ertapenem using the strip-test (bioMerieux, La
Balme-les-Grottes, France). The presence of blaoxa-48 was
controlled in all isolates and blaESBL genes were identified in
ESBL-producers by sequencing [5]. Pulsed-field gel electro-
phoresis (PFGE) was performed using the XbaI and multilo-
cus sequence typing (MLST) was performed as previously
described [6]. In order to build a dendrogram with the 1392
STs available at the time of the study, we concatenated the
sequences of seven MLST genes to form a 3078-bp sequence
alignment and define 930 polymorphic positions. The best-fit
nucleotide substitution model for these data was GTR+G+I,
as determined with jModelTest 0.1.1 [7]. We used Escherichia
coli K12 as the outgroup strain. A maximum likelihood tree
was constructed with RAxML 7.2.8 and visualized with
Dendroscope [8].
According to the EUCAST guidelines, 93% of the 53
OXA-48-Kp isolates were non-susceptible to ertapenem, 23%
non-susceptible to imipenem and 17% non-susceptible to
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meropenem. Most of the OXA-48-Kp isolates (42/53; 79%)
produced an ESBL, with a large predominance of CTX-M-15
(40/42; 95%). The production of an ESBL was not linked to
previous travel abroad. ESBL-producing OXA-48-Kp isolates
were more frequently resistant to ertapenem, extended-spec-
trum cephalosporins, tobramycin and fluoroquinolones than
non-ESBL-producers (p <0.01).
The 53 OXA-48-Kp isolates were distributed into 20 STs.
ST15 was the most frequent ST (14 isolates; 26%), followed by
ST147 and ST395 (six isolates each; 11%) and ST101 and
ST405 (five isolates each; 9%). ST17, ST48 and ST70 were
represented by two isolates each. Other STs were repre-
sented by one isolate (ST37, ST45, ST231, ST307, ST336,
ST589, ST663, ST1299, ST1300, ST1382 and ST1383). Isolates
belonging to dominant STs (ST15, ST101, ST147, ST395, and
ST405) were more likely to produce an ESBL (92% vs. 53%;
p 0.001) and more likely to be resistant to extended-spectrum
cephalosporins, tobramycin and fluoroquinolones (p <0.01)
than isolates from non-dominant STs. Of interest, isolates
from patients with a prior history of international travel were
found in both dominant and non-dominant STs.
The phylogenetic tree built from the sequence data of the
seven MLST genes of the 1392 STs of K. pneumoniae clearly
showed three major clades, which correspond to the three
major phylogenetic groups (KpI, KpII and KpIII) (Fig. 1). These
three clades have been previously defined by the comparison
of gyrA and parC sequences [9]. The majority (75%) of the 1392
defined STs clustered into the clade KpI, which encompassed
all the 53 OXA-48-Kp of the present study (Fig. 1).
Here we found that 79% of the emerging OXA-48-Kp in
France additionally produced an ESBL, mostly of
CTX-M-15-type. Such a proportion and the large predomi-
nance of CTX-M-15 have also been observed by Potron et al.
[10] in an international collection. In our collection of
OXA-48-Kp, the ESBL production was associated with a
higher resistance to extended-spectrum cephalosporins and to
fluoroquinolones. It is worth mentioning that 77% and 83% of
our OXA-48-Kp remain susceptible to imipenem and me-
ropenem, respectively. The analysis of MLST data revealed that
a quarter of OXA-48-Kp belonged to ST15, while four other
clones (ST101, ST147, ST395 and ST405) were represented
each by five or six isolates These STs are recognized as
established ‘international’ clones that predominantly har-
boured blaESBL genes and less frequently carbapenem-
ase-encoding genes. However, these clones have not yet had
the epidemiological success of ST258, which drives the
worldwide dissemination of blaKPC [2]. Overall, this suggests
that the spread of OXA-48-Kp combines the clonal expansion
of successful STs and the dissemination of plasmid-borne
blaOXA-48 among various strains of K. pneumoniae. Indeed, a
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FIG. 1. Comparative analysis based on
concatenated sequences of the seven
housekeeping genes of the Klebsiella
pneumonia MLST scheme. (A) Clonal
assignment of the STs in the entire
K. pneumonia MLST database (n = 1392
STs). (B) Close-up of the KpI group. The
STs found in the present collection are
represented with red spots.
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62-kb self-conjugative IncL/M-type plasmid has been shown to
contribute to the diffusion of blaOXA48 in Europe [11]. Also,
the genetic association of the blaCTX-M-15 and blaOXA-48 genes on
mobile genetic elements, which may easily spread among
Enterobacteriaceae, is a matter of concern [12].
The phylogenetic tree built with the whole MLST database
reveals that all the STs recovered in this study clustered in the
KpI group, the clade that includes all the multidrug-resistant
clinical isolates [13]. The scattering of our OXA-48 Kp isolates
throughout the KpI group suggests that the acquisition of
blaOXA-48 is not associated with a subset of KpI strains.
Interestingly, our study, together with the French national
survey [14], shows that approximately one-quarter of
OXA-48-Kp could be autochthonous (i.e. with no history of
travel or hospitalization abroad) and independent from a
previous hospitalization in a French hospital.
In conclusion, emergence and spread of OXA-48-Kp is
nowadays a public health concern, because of therapeutic
dead-ends and risk of transmission of the blaOXA-48 gene to
commensal E. coli clones. The ‘search and isolate’ French
policy regarding CPE in hospitals has been demonstrated to be
an efficient tool until now because most of the reported CPE
episodes remained sporadic. However, such infection control
measures will be difficult to maintain if the amount of blaOXA-48
continues to increase.
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